Nature Reviews Endocrinology

Papers
(The TQCC of Nature Reviews Endocrinology is 60. The table below lists those papers that are above that threshold based on CrossRef citation counts. The publications cover those that have been published in the past four years, i.e., from 2019-03-01 to 2023-03-01.)
ArticleCitations
Obesity: global epidemiology and pathogenesis1709
Gut microbial metabolites in obesity, NAFLD and T2DM586
Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification315
Circadian clocks and insulin resistance296
Rethinking mechanisms, diagnosis and management of endometriosis284
Physical activity and muscle–brain crosstalk279
The human stress response278
Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus267
The endocrine function of adipose tissues in health and cardiometabolic disease258
Function and mechanisms of enteroendocrine cells and gut hormones in metabolism247
The obese adipose tissue microenvironment in cancer development and progression247
The circadian regulation of food intake187
The role of hypoxia-inducible factors in metabolic diseases180
The heterogeneous pathogenesis of type 1 diabetes mellitus175
The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases161
Geographic influences in the global rise of thyroid cancer153
Circadian rhythms and exercise — re-setting the clock in metabolic disease144
Inter-tissue communication in cancer cachexia138
A road map for understanding molecular and genetic determinants of osteoporosis134
Bile acids in glucose metabolism and insulin signalling — mechanisms and research needs130
Melatonin in type 2 diabetes mellitus and obesity130
The role of macrophages in obesity-associated islet inflammation and β-cell abnormalities127
The clinical potential of circulating microRNAs in obesity120
Microbiota and metabolites in metabolic diseases119
The role of osteoblasts in energy homeostasis115
Turner syndrome: mechanisms and management114
Sperm RNA code programmes the metabolic health of offspring113
Post-transplant diabetes mellitus in patients with solid organ transplants105
Deiodinases and their intricate role in thyroid hormone homeostasis105
The regulation of hepatic fatty acid synthesis and partitioning: the effect of nutritional state105
Endocrine disruptors and the future of toxicology testing — lessons from CLARITY–BPA105
Prolactin — a pleiotropic factor in health and disease99
New insights into the pathogenesis and nonsurgical management of Graves orbitopathy99
Combating osteoporosis and obesity with exercise: leveraging cell mechanosensitivity94
The role of thyroglobulin in thyroid hormonogenesis92
Molecular pathways linking adipose innervation to insulin action in obesity and diabetes mellitus90
Fracture prediction, imaging and screening in osteoporosis86
Interconnection between circadian clocks and thyroid function84
From conception to infancy — early risk factors for childhood obesity80
Mechanisms of weight regain after weight loss — the role of adipose tissue76
The blood–brain barrier as an endocrine tissue71
Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseases71
Adrenal function and dysfunction in critically ill patients67
Adrenocortical carcinoma — towards genomics guided clinical care65
Inhibiting PCSK9 — biology beyond LDL control65
The effects of growth hormone on adipose tissue: old observations, new mechanisms62
The arrival of circadian medicine61
Obesity: a neuroimmunometabolic perspective60
0.708251953125